![Pierre Jacquet](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pierre Jacquet
Directeur/Membre du Conseil chez
MEREO BIOPHARMA GROUP PLC
Fortune : - $ au 30/06/2026
Profil
Pierre Jacquet currently works at The Lek, as Vice Chairman & MD-Global Healthcare, L.E.K.
Consulting LLC, as Vice Chairman & MD-Healthcare Practice from 2001, and Mereo BioPharma Group Plc, as Independent Director from 2021.
Dr. Jacquet also formerly worked at Osprey Pharmaceuticals USA, Inc., as Director, EXACT Sciences Corp., as Independent Director, Genzyme Corp., as Head-Business Development, Arthur D.
Little, Inc., as Manager from 1998 to 2000, and Transfer Technologies Commercialisation Capital, as Advisor.
Dr. Jacquet received his doctorate degree in 1996 from the University of Liege and Masters Business Admin degree in 1998 from the University of Virginia Darden School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Pierre Jacquet
| Sociétés | Poste | Début |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Directeur/Membre du Conseil | 20/09/2021 |
The Lek/Alcar Consulting Group, Inc.
 The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Directeur/Membre du Conseil | - |
L.E.K. Consulting LLC
 L.E.K. Consulting LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic consulting services | Directeur/Membre du Conseil | 01/01/2001 |
Anciens postes connus de Pierre Jacquet
| Sociétés | Poste | Fin |
|---|---|---|
| EXACT SCIENCES CORPORATION | Directeur/Membre du Conseil | 13/06/2024 |
Arthur D. Little, Inc.
 Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Corporate Officer/Principal | 01/01/2000 |
Osprey Pharmaceuticals USA, Inc.
 Osprey Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics | Directeur/Membre du Conseil | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
Transfer Technologies Commercialisation Capital
 Transfer Technologies Commercialisation Capital Investment ManagersFinance T²C² seeks to identify (in universities, research centers and industry) business opportunities and turn them into real businesses. They invest in health sciences, with an emphasis on biotechnology, pharmaceuticals and medical equipment. Criteria that are necessary for the selection of a project are: excellent quality of science and technology, complementarities and equilibrium of the team, intellectual property and market potential. | Corporate Officer/Principal | - |
Formation de Pierre Jacquet
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
EXACT Sciences Corp.
 EXACT Sciences Corp. Medical SpecialtiesHealth Technology Develops proprietary technologies for the detection of cancer | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Osprey Pharmaceuticals USA, Inc.
Osprey Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics | Health Technology |
Arthur D. Little, Inc.
Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
The Lek/Alcar Consulting Group, Inc.
The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Commercial Services |
Transfer Technologies Commercialisation Capital
Transfer Technologies Commercialisation Capital Investment ManagersFinance T²C² seeks to identify (in universities, research centers and industry) business opportunities and turn them into real businesses. They invest in health sciences, with an emphasis on biotechnology, pharmaceuticals and medical equipment. Criteria that are necessary for the selection of a project are: excellent quality of science and technology, complementarities and equilibrium of the team, intellectual property and market potential. | Finance |
University of Liege
 University of Liege Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
L.E.K. Consulting LLC
L.E.K. Consulting LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic consulting services | Commercial Services |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mereo BioPharma Group Plc
 Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
